Nick Teoh

Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus

Thomas Dörner, Joerg Kaufmann, William A. Wegener et al. · Arthritis Research & Therapy · 2006 · 307 citations · Full text

Life Sciences, Immunology, Pharmacology +16

Durable complete responses from therapy with combined epratuzumab and rituximab

John P. Leonard, Stephen J. Schuster, Christos Emmanouilides et al. · Cancer · 2008 · 102 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Initial Safety and Efficacy Results of a Second-Generation Humanized Anti-CD20 Antibody, IMMU-106 (hA20), in Non-Hodgkin’s Lymphoma.

Franck Morschhauser, John P. Leonard, Bertrand Coiffier et al. · Blood · 2005 · 26 citations

Medicine, Hematology, Oncology +14

Dose-escalation trial of milatuzumab (humanized anti-CD74 monoclonal antibody) in multiple myeloma

Jonathan L. Kaufman, Rubén Niesvizky, Edward A. Stadtmauer et al. · Journal of Clinical Oncology · 2009 · 21 citations

Medicine, Hematology, Oncology +17

Entropy-Based Random Number Evaluation

Edward J. Dudewicz, Edward C. van der Meulen, M. G. Sriram et al. · American Journal of Mathematical and Management Sciences · 1995 · 17 citations

Natural Sciences, Mathematics, Probability Theory +13